MediWound Ltd

(NASDAQ:MDWD)

Latest On MediWound Ltd (MDWD):

Date/Time Type Description Signal Details
2023-05-31 22:31 ESTNewsMediWound: With Expenses Covered, Growth Is Within ReachN/A
2023-05-30 17:26 ESTNewsMediWound GAAP EPS of -$0.44 misses by $0.26, revenue of $3.8M misses by $1.35MN/A
2023-05-30 17:26 ESTNewsMediWound Ltd. (MDWD) Q1 2023 Earnings Call TranscriptN/A
2023-05-30 17:26 ESTNewsMediWound slips after Q1 missN/A
2023-05-27 03:57 ESTNewsMediWound Q1 Earnings PreviewN/A
2023-03-16 20:36 ESTNewsMediWound names industry veteran as CFON/A
2023-03-16 20:36 ESTNewsMediWoundEPS of -$1.18, revenue of $11.62M beats by $5.02MN/A
2023-03-16 20:36 ESTNewsMediWound Ltd. (MDWD) Q4 2022 Earnings Call TranscriptN/A
2023-03-15 13:53 ESTNewsMediWound Q4 2022 Earnings PreviewN/A
2023-01-04 21:36 ESTNewsMediWound: Gaining TractionN/A
2022-12-29 20:29 ESTNewsMediWound, Vericel gain on FDA approval of burn therapyN/A
2022-12-23 10:45 ESTNewsMediWound's burn treatment Nexobrid approved in JapanN/A
2022-12-20 15:02 ESTNewsMediWound gets Swiss marketing approval for burns treatment NexoBridN/A
2022-12-06 04:24 ESTNewsMediWound announces 1-for-7 reverse share splitN/A
2022-11-15 21:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $5.8M beats by $1.2MN/A
2022-11-15 21:57 ESTNewsMediWound Ltd. (MDWD) Q3 2022 Earnings Call TranscriptN/A
2022-11-15 04:52 ESTNewsMediWound Q3 2022 Earnings PreviewN/A
2022-09-22 20:26 ESTNewsMediWound stock slips on ~$30.5M securities offeringsN/A
2022-09-20 19:14 ESTNewsMediWound's NexoBrid for thermal burns in children gets EMA reviewN/A
2022-08-10 02:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61MN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. (MDWD) CEO Ofer Gonen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 05:06 ESTNewsMediWound Q2 Earnings PreviewN/A
2022-08-03 23:17 ESTNewsMediWound refiling for NexoBrid to treat severe thermal burns gets FDA reviewN/A
2022-07-07 15:49 ESTNewsMediWound adds 13% after favorable data for ulcer candidateN/A
2022-06-30 13:41 ESTNewsMediWound taps Tzvi Palash as COON/A
2022-05-17 12:25 ESTNewsMediWound GAAP EPS of -$0.12 misses by $0.01, revenue of $4.4M beats by $0.11MN/A
2022-05-17 12:25 ESTNewsMediWound picks industry veteran for CEO roleN/A
2022-05-17 12:25 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 15:11 ESTNewsMediWound Q1 2022 Earnings PreviewN/A
2022-03-17 15:21 ESTNewsMediWound Q4 2021 Earnings PreviewN/A
2022-03-17 15:20 ESTNewsMediWound GAAP EPS of -$0.15 in-line, revenue of $5.49M misses by $0.05MN/A
2022-03-17 15:19 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 14:30 ESTNewsMediWound slumps on pricing $10M stock offeringN/A
2022-03-02 20:11 ESTNewsMediWound slides on proposed stock offeringN/A
2022-02-10 11:47 ESTNewsMediWound wins $9M additional BARDA funding for NexoBridN/A
2022-01-24 07:28 ESTNewsMediWound reports positive results from Phase 2 trial of EscharEx for debridement of chronic woundsN/A
2021-12-20 10:51 ESTNewsMediWound reports positive initial data from Phase 2 EscharEx study in chronic, hard to heal woundsN/A
2021-11-17 00:12 ESTNewsMediWound EPS beats by $0.01, beats on revenueN/A
2021-11-17 00:12 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:19 ESTNewsMediWound Q3 2021 Earnings PreviewN/A
2021-10-13 04:34 ESTNewsWarning: MDWD is at high risk of performing badlyN/A
2021-10-06 12:47 ESTNewsMDWD is at high risk of performing badlyN/A
2021-09-27 21:29 ESTNewsWarning: MDWD has been downgraded to Very BearishN/A
2021-09-22 00:18 ESTNewsWarning: MDWD has been downgraded to Very Bearish.N/A
2021-08-11 04:24 ESTNewsMediwound Ltd (MDWD) CEO Sharon Malka on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 07:32 ESTNewsMediWound EPS misses by $0.01, beats on revenueN/A
2021-07-30 17:24 ESTNewsMediWound: Disappointing Thus Far But Still A Strong BuyN/A
2021-07-29 01:24 ESTNewsMediWound: Adjusting My Strategy After NexoBrid CRLN/A
2021-07-21 15:33 ESTNewsMediWound completes enrollment for interim assessment of mid-stage EscharEx studyN/A

About MediWound Ltd (MDWD):

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

See Advanced Chart

General

  • Name MediWound Ltd
  • Symbol MDWD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 75
  • Fiscal Year EndDecember
  • IPO Date2014-03-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.mediwound.com
View More

Valuation

  • Trailing PE 27.07
  • Price/Sales (Trailing 12 Mt.) 7.03
  • Price/Book (Most Recent Quarter) 21.05
  • Enterprise Value Revenue 6.13
  • Enterprise Value EBITDA 15.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.24
  • Next Year EPS Estimate -$0.54
  • Next Quarter EPS Estimate -$0.12
  • Profit Margin -42%
  • Operating Margin -40%
  • Return on Assets -15%
  • Return on Equity -83%
  • Revenue 21.76 million
  • Earnings Per Share $0.24
  • Revenue Per Share $0.8
  • Gross Profit 7.55 million
  • Quarterly Earnings Growth 22.6%
View More

Highlights

  • Market Capitalization 155.8 million
  • EBITDA 8.18 million
  • PE Ratio -9.93
  • PEG Ratio -0.07
  • Analyst Target Price $7.67
  • Book Value Per Share $0.27
View More

Share Statistics

  • Shares Outstanding 27.24 million
  • Shares Float 16.8 million
  • % Held by Insiders 4277%
  • % Held by Institutions 18.85%
  • Shares Short 33009
  • Shares Short Prior Month 21560
  • Short Ratio 0.22
View More

Technicals

  • Beta 1.54
  • 52 Week High $6.07
  • 52 Week Low $1.44
  • 50 Day Moving Average 5.41
  • 200 Day Moving Average 4.22
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

MediWound Ltd (MDWD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MediWound Ltd (MDWD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.06-$0.1145.45%
2020-09-302020-11-10$6.63 million-$0.07-$0.1027.08%
2020-06-302020-08-06$N/A-$0.11-$0.128.33%
2020-03-312020-05-20$4.44 million-$0.09-$0.1436.84%
2019-12-312020-02-25$5.44 million-$0.13-$0.10-25%
2019-09-302019-11-14$5.14 million-$0.11-$0.1315.38%
2019-06-302019-08-12$20.75 million$0.47-$0.031907.69%
2019-03-312019-05-21$461000-$0.15-$0.14-7.14%
2018-12-312019-03-25$992000$0.22-$0.15244.74%
2018-09-302018-11-13$858000-$0.11-$0.2043.88%
2018-06-302018-08-07$1.03 million-$0.15-$0.2023.47%
2018-03-312018-05-10$520000-$0.17-$0.14-25.93%
2017-12-312018-03-19$530000-$0.08-$0.1854.93%
2017-09-302017-11-16$739000-$0.16-$0.1915.79%
2017-06-302017-08-03$687000-$0.20-$0.20-2.04%
2017-03-312017-05-08$540000-$0.20-$0.17-19.05%
2016-12-312017-02-21$430000-$0.09-$0.2563.71%
2016-09-302016-11-14$518000-$0.26-$0.26-0.97%
2016-06-302016-07-28$356000-$0.34-$0.24-42.68%
2016-03-312016-04-21$254000-$0.17-$0.2429.52%
2015-12-312016-01-25$267000-$0.36-$0.23-54.51%
2015-09-302015-10-27$102000-$0.17-$0.3145.16%
2015-06-302015-08-03$165000-$0.19-$0.2626.92%
2015-03-312015-05-04$67000-$0.30-$0.25-20%
2014-12-312015-02-12$124000-$0.33-$0.26-26.92%
2014-09-302014-11-05$46000-$0.24-$0.240%
2014-06-302014-07-31$39000-$0.28-$0.17-64.71%
2014-03-312014-05-02$50000-$0.05-$0.1770.59%

MediWound Ltd (MDWD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MediWound Ltd (MDWD) Chart:

MediWound Ltd (MDWD) News:

Below you will find a list of latest news for MediWound Ltd (MDWD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MediWound Ltd (MDWD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-15100CALL0 0281.51TRUE00
2025-08-15120CALL0 0228.37TRUE00
2025-08-15130CALL0 0201.91TRUE00
2025-08-15140CALL0 0182.08TRUE00
2025-08-15150CALL0 0153.97TRUE00
2025-08-15160CALL0 0131.77TRUE00
2025-08-15170CALL0 0115.83TRUE00
2025-08-15180CALL0 099.13TRUE00
2025-08-15192.2CALL0 184.17TRUE00
2025-08-15201.4CALL0 141.04TRUE00
2025-08-15210.8CALL0 7391.9FALSE00
2025-08-15220.5CALL0 33192.46FALSE00
2025-08-15230.4CALL0 21110.14FALSE00
2025-08-15240.4CALL0 6103.93FALSE00
2025-08-15250CALL0 0136.26FALSE00
2025-08-15260CALL0 0146.73FALSE00
2025-08-15270CALL0 0156.24FALSE00
2025-08-15280CALL0 0166.52FALSE00
2025-08-15100PUT0 0292.42FALSE00
2025-08-15120PUT0 0232.16FALSE00
2025-08-15130PUT0 0240.29FALSE00
2025-08-15140PUT0 0180.88FALSE00
2025-08-15150PUT0 0157.51FALSE00
2025-08-15160PUT0 0162.12FALSE00
2025-08-15170.38PUT0 100138.26FALSE00
2025-08-15180.4PUT0 1103.74FALSE00
2025-08-15190.55PUT0 353.9FALSE00
2025-08-15200.7PUT22 31946.45FALSE-0.03-0.04
2025-08-15211.58PUT0 1070.81TRUE00
2025-08-15220PUT0 084.35TRUE00
2025-08-15230PUT0 088.79TRUE00
2025-08-15240PUT0 091.43TRUE00
2025-08-15250PUT0 0101.71TRUE00
2025-08-15260PUT0 0112.68TRUE00
2025-08-15270PUT0 0119.04TRUE00
2025-08-15280PUT0 0120.1TRUE00
2025-09-1950CALL0 0225.76TRUE00
2025-09-19100CALL0 0166.92TRUE00
2025-09-19110CALL0 0148.27TRUE00
2025-09-19120CALL0 0134.96TRUE00
2025-09-19130CALL0 0119.03TRUE00
2025-09-19140CALL0 0104.2TRUE00
2025-09-19150CALL0 098.36TRUE00
2025-09-19164.5CALL0 4360.22TRUE00
2025-09-19170CALL0 883.76TRUE00
2025-09-19182.78CALL0 4276.14TRUE00
2025-09-19190CALL0 071.77TRUE00
2025-09-19201.5CALL0 5563.16TRUE00
2025-09-19211.47CALL0 8461.43FALSE00
2025-09-19221.85CALL0 32349.03FALSE00
2025-09-19231.22CALL0 1672.17FALSE00
2025-09-19240.6CALL0 1160.95FALSE00
2025-09-19250.47CALL10 6555.99FALSE0.470
2025-09-19260CALL0 1065.98FALSE00
2025-09-19270CALL0 090.64FALSE00
2025-09-19280.3CALL0 4097.78FALSE00
2025-09-19290.2CALL0 30102.58FALSE00
2025-09-19300.22CALL1 246468.57FALSE0.220
2025-09-19310CALL0 0112.13FALSE00
2025-09-19320CALL0 0119.1FALSE00
2025-09-19330CALL0 0112.71FALSE00
2025-09-19340CALL0 0107.01FALSE00
2025-09-19350.66CALL0 1304100.76FALSE00
2025-09-1950PUT0 0322.87FALSE00
2025-09-19100PUT0 0204.31FALSE00
2025-09-19110PUT0 0182.97FALSE00
2025-09-19120PUT0 2142.48FALSE00
2025-09-19130PUT0 3278.77FALSE00
2025-09-19140PUT0 3130.46FALSE00
2025-09-19150PUT0 073.67FALSE00
2025-09-19160PUT0 2101.99FALSE00
2025-09-19170.32PUT0 3590.43FALSE00
2025-09-19180.57PUT0 4643.86FALSE00
2025-09-19190PUT0 469.97FALSE00
2025-09-19200PUT0 156.73FALSE00
2025-09-19211.86PUT0 368.75TRUE00
2025-09-19220PUT0 070.38TRUE00
2025-09-19230PUT0 070.86TRUE00
2025-09-19240PUT0 071.24TRUE00
2025-09-19250PUT0 079.22TRUE00
2025-09-19265.65PUT0 1064.02TRUE00
2025-09-19270PUT0 079.26TRUE00
2025-09-19280PUT0 091.67TRUE00
2025-09-19290PUT0 097.48TRUE00
2025-09-19300PUT0 086.34TRUE00
2025-09-19310PUT0 093.86TRUE00
2025-09-19320PUT0 098.54TRUE00
2025-09-19330PUT0 090.85TRUE00
2025-09-19340PUT0 0112.61TRUE00
2025-09-19350PUT0 0111.39TRUE00
2025-12-1980CALL0 0121.44TRUE00
2025-12-1990CALL0 0107.15TRUE00
2025-12-19109.53CALL0 197.53TRUE00
2025-12-19118.65CALL0 188.68TRUE00
2025-12-19120CALL0 080.41TRUE00
2025-12-19130CALL0 076.71TRUE00
2025-12-19140CALL0 072.42TRUE00
2025-12-19156.62CALL12 7069.86TRUE6.620
2025-12-19160CALL0 064.02TRUE00
2025-12-19170CALL0 161TRUE00
2025-12-19184.6CALL0 3056.09TRUE00
2025-12-19190CALL0 050.66TRUE00
2025-12-19202.84CALL0 1251.19TRUE00
2025-12-19213.2CALL0 1560.82FALSE00
2025-12-19222.32CALL0 3375.56FALSE00
2025-12-19231.96CALL0 251.27FALSE00
2025-12-19241.4CALL0 3467.92FALSE00
2025-12-19251.52CALL0 1556.58FALSE00
2025-12-19260.9CALL0 1066.47FALSE00
2025-12-19270.8CALL0 1059.02FALSE00
2025-12-19280.55CALL0 3171.77FALSE00
2025-12-19290.55CALL0 11064.84FALSE00
2025-12-19301.14CALL1 37368.62FALSE1.140
2025-12-19310CALL0 072.71FALSE00
2025-12-19320CALL0 079.97FALSE00
2025-12-19330CALL0 076.21FALSE00
2025-12-19340CALL0 479.61FALSE00
2025-12-19350.76CALL1 8572.92FALSE0.760
2025-12-1980PUT0 0137.64FALSE00
2025-12-1990PUT0 0141.44FALSE00
2025-12-19100PUT0 0126.78FALSE00
2025-12-19110PUT0 0113.67FALSE00
2025-12-19120PUT0 0101.76FALSE00
2025-12-19130PUT0 092.58FALSE00
2025-12-19140.65PUT0 283.87FALSE00
2025-12-19150.9PUT0 268.01FALSE00
2025-12-19161.2PUT0 156.26FALSE00
2025-12-19171.4PUT0 565.06FALSE00
2025-12-19181.81PUT0 961.85FALSE00
2025-12-19192.15PUT0 558.45FALSE00
2025-12-19202.8PUT0 757.79FALSE00
2025-12-19210PUT0 058.57TRUE00
2025-12-19223.16PUT0 252.96TRUE00
2025-12-19230PUT0 061.13TRUE00
2025-12-19240PUT0 057.12TRUE00
2025-12-19250PUT0 056.22TRUE00
2025-12-19260PUT0 059.96TRUE00
2025-12-19270PUT0 059.9TRUE00
2025-12-19280PUT0 062.82TRUE00
2025-12-19290PUT0 062.9TRUE00
2025-12-19300PUT0 059.53TRUE00
2025-12-19310PUT0 068.49TRUE00
2025-12-19320PUT0 067.4TRUE00
2025-12-19330PUT0 068.85TRUE00
2025-12-19340PUT0 076.24TRUE00
2025-12-19350PUT0 072.76TRUE00
2026-03-20120CALL0 066.9TRUE00
2026-03-20130CALL0 067.85TRUE00
2026-03-20140CALL0 062.18TRUE00
2026-03-20150CALL0 061.38TRUE00
2026-03-20160CALL0 055.5TRUE00
2026-03-20170CALL0 055.56TRUE00
2026-03-20180CALL0 057.41TRUE00
2026-03-20190CALL0 058.24TRUE00
2026-03-20200CALL0 051.03TRUE00
2026-03-20210CALL0 056.9FALSE00
2026-03-20220CALL0 058.06FALSE00
2026-03-20230CALL0 059.04FALSE00
2026-03-20240CALL0 058.36FALSE00
2026-03-20250CALL0 054.1FALSE00
2026-03-20260CALL0 056.38FALSE00
2026-03-20270CALL0 053.46FALSE00
2026-03-20281.95CALL6 061.2FALSE1.950
2026-03-20120PUT0 073.81FALSE00
2026-03-20130PUT0 067.26FALSE00
2026-03-20140PUT0 064.28FALSE00
2026-03-20150PUT0 061.47FALSE00
2026-03-20160PUT0 057.18FALSE00
2026-03-20170PUT0 055.09FALSE00
2026-03-20180PUT0 058.65FALSE00
2026-03-20190PUT0 059.72FALSE00
2026-03-20200PUT0 054.37FALSE00
2026-03-20210PUT0 054.13TRUE00
2026-03-20220PUT0 055.17TRUE00
2026-03-20230PUT0 051.72TRUE00
2026-03-20240PUT0 055.44TRUE00
2026-03-20250PUT0 054.35TRUE00
2026-03-20260PUT0 056.8TRUE00
2026-03-20270PUT0 058.08TRUE00
2026-03-20280PUT0 064.07TRUE00

Latest MDWD Trades:

Date Shares Price
Jun 13, 2022 2:52 PM EST200$1.74

MediWound Ltd (MDWD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1593984/000000000019006753/0000000000-19-006753-index.htm
2017-02-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000257/0000902219-17-000257-index.htm
2017-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000560/0000902219-17-000560-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221918000039/0000902219-18-000039-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221919000059/0000902219-19-000059-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000291/0000902219-20-000291-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000393/0000902219-20-000393-index.htm
2017-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000232/0001178913-17-000232-index.htm
2017-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000245/0001178913-17-000245-index.htm
2017-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000255/0001178913-17-000255-index.htm
2017-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000291/0001178913-17-000291-index.htm
2017-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000310/0001178913-17-000310-index.htm
2017-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000371/0001178913-17-000371-index.htm
2017-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000573/0001178913-17-000573-index.htm
2017-02-2120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000577/0001178913-17-000577-index.htm
2017-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001307/0001178913-17-001307-index.htm
2017-05-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001527/0001178913-17-001527-index.htm
2017-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001531/0001178913-17-001531-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001883/0001178913-17-001883-index.htm
2017-07-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002090/0001178913-17-002090-index.htm
2017-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002253/0001178913-17-002253-index.htm
2017-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002600/0001178913-17-002600-index.htm
2017-09-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317002608/0001178913-17-002608-index.htm
2017-09-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002630/0001178913-17-002630-index.htm
2017-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002691/0001178913-17-002691-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002695/0001178913-17-002695-index.htm
2017-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002697/0001178913-17-002697-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002703/0001178913-17-002703-index.htm
2017-10-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002869/0001178913-17-002869-index.htm
2017-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002900/0001178913-17-002900-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003131/0001178913-17-003131-index.htm
2017-11-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003176/0001178913-17-003176-index.htm
2018-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000170/0001178913-18-000170-index.htm
2018-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000211/0001178913-18-000211-index.htm
2018-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000314/0001178913-18-000314-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000365/0001178913-18-000365-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000428/0001178913-18-000428-index.htm
2018-02-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000676/0001178913-18-000676-index.htm
2018-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000885/0001178913-18-000885-index.htm
2018-03-1920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000887/0001178913-18-000887-index.htm
2018-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000892/0001178913-18-000892-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001565/0001178913-18-001565-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001584/0001178913-18-001584-index.htm
2018-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001883/0001178913-18-001883-index.htm
2018-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001923/0001178913-18-001923-index.htm
2018-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001929/0001178913-18-001929-index.htm
2018-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002304/0001178913-18-002304-index.htm
2018-09-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002568/0001178913-18-002568-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002903/0001178913-18-002903-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000121/0001178913-19-000121-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000309/0001178913-19-000309-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000381/0001178913-19-000381-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000454/0001178913-19-000454-index.htm
2019-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000792/0001178913-19-000792-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000909/0001178913-19-000909-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000911/0001178913-19-000911-index.htm
2019-03-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/0001178913-19-000913-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000920/0001178913-19-000920-index.htm
2019-03-25F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000922/0001178913-19-000922-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000924/0001178913-19-000924-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001120/0001178913-19-001120-index.htm
2019-04-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001183/0001178913-19-001183-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001289/0001178913-19-001289-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001363/0001178913-19-001363-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001559/0001178913-19-001559-index.htm
2019-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001605/0001178913-19-001605-index.htm
2019-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001690/0001178913-19-001690-index.htm
2019-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001934/0001178913-19-001934-index.htm
2019-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002149/0001178913-19-002149-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002192/0001178913-19-002192-index.htm
2019-08-236-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002251/0001178913-19-002251-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002438/0001178913-19-002438-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002449/0001178913-19-002449-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002453/0001178913-19-002453-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002734/0001178913-19-002734-index.htm
2019-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002874/0001178913-19-002874-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000022/0001178913-20-000022-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000279/0001178913-20-000279-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000291/0001178913-20-000291-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000638/0001178913-20-000638-index.htm
2020-02-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/0001178913-20-000640-index.htm
2020-02-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000647/0001178913-20-000647-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000649/0001178913-20-000649-index.htm
2020-02-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000651/0001178913-20-000651-index.htm
2020-03-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000684/0001178913-20-000684-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000956/0001178913-20-000956-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001215/0001178913-20-001215-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001535/0001178913-20-001535-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001551/0001178913-20-001551-index.htm
2020-06-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001896/0001178913-20-001896-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002286/0001178913-20-002286-index.htm
2020-08-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002493/0001178913-20-002493-index.htm
2020-09-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002640/0001178913-20-002640-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002913/0001178913-20-002913-index.htm
2020-10-306-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002949/0001178913-20-002949-index.htm
2017-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312517043820/0001193125-17-043820-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312518045765/0001193125-18-045765-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312519039173/0001193125-19-039173-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390019002073/0001213900-19-002073-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390020001894/0001213900-20-001894-index.htm
2019-04-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1593984/999999999519000785/9999999995-19-000785-index.htm
2017-02-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717001269/9999999997-17-001269-index.htm
2017-03-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717003766/9999999997-17-003766-index.htm
2019-04-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999719002564/9999999997-19-002564-index.htm